HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or...
Vous n'êtes pas connecté
CRANBURY, N.J., June 20, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced the initiation of a Phase 2...
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or...
The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...
The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...
RenovoRx, Inc, a clinical─stage biopharmaceutical company developing novel precision oncology therapies based on a local drug─delivery platform,...
PTC Therapeutics, Inc, a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated...
CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
KalVista initiates KONFIDENT-KID trial for on-demand treatment of hereditary angioedema attacks with sebetralstat in children aged 2 to 11 KalVista...
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of...
GENEVA, Switzerland – The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are...